Jillian Dietzold

Divergent Functions of TLR2 on Hematopoietic and Nonhematopoietic Cells during Chronic Mycobacterium tuberculosis Infection

P. Salgame, S. Verma, Jill Konowich, 2017, The Journal of Immunology.

Duality of lipid mediators in host response against Mycobacterium tuberculosis: good cop, bad cop

P. Salgame, A. Gopalakrishnan, Jillian Dietzold, 2015, F1000prime reports.

Toll-like Receptor 2 Prevents Neutrophil-Driven Immunopathology during Infection with Mycobacterium tuberculosis by Curtailing CXCL5 Production

P. Salgame, S. Verma, A. Gopalakrishnan, 2018, Infection and Immunity.

Ethambutol Partitioning in Tuberculous Pulmonary Lesions Explains Its Clinical Efficacy

M. Zimmerman, V. Dartois, Steven Park, 2017, Antimicrobial Agents and Chemotherapy.

Comparing efficacies of moxifloxacin, levofloxacin and gatifloxacin in tuberculosis granulomas using a multi-scale systems pharmacology approach

Brendan Prideaux, Denise E. Kirschner, Jennifer J. Linderman, 2017, PLoS Comput. Biol..

Fluoroquinolone Efficacy against Tuberculosis Is Driven by Penetration into Lesions and Activity against Resident Bacterial Populations

D. Kirschner, J. Linderman, M. Zimmerman, 2019, Antimicrobial Agents and Chemotherapy.

Vaccine-mediated immunity to experimental Mycobacterium tuberculosis is not impaired in the absence of Toll-like receptor 9.

P. Salgame, A. Gopalakrishnan, Jillian Dietzold, 2016, Cellular immunology.